are glp 1 patches as effective as injections Gentle GLP-1 Review: Innovation or Illusion? GLP-1 Patches: Do They Work?
Description
On February 21, 2024, the FDA announced the end of the shortage of Ozempic and Wegovy
These are also known as GLP-1 agonists, incretin mimetics, or GLP-1 analogs
To put that into perspective, if starting BMI was 32, a 16% reduction would bring it down to 27
In this population, GLP-1 agonist use was associated with a 15% reduced risk of developing dry AMD and a 20% lower risk of wet AMD compared to other antidiabetic medications
Therefore, primarily overweight individuals with AUD should be considered for treatment with GLP-1R agonists
